SCHEMBL215851

SCHEMBL215851

OCCC1=NCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6231816 0.88
SCHEMBL351538 0.85 ADRA2A (0.34)
SCHEMBL6244828 0.85
SCHEMBL351887 0.80 ADRA2A (0.32)
SCHEMBL5108997 0.80
SCHEMBL976195 0.80
SCHEMBL353044 0.80 ADRA2A (0.32)
SCHEMBL9219543 0.78 ADRA2A (0.31)
SCHEMBL471908 0.78 ADRA2A (0.32)
SCHEMBL10410293 0.78 ADRA2A (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 830 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240075150-A1 CONJUGATES COMPRISING REVERSIBLE LINKERS AND USES THEREOF ASCENDIS PHARMA A/S (DK) 2024-03-07 US claimed
CN-117355337-A Protein-macromolecule conjugates and methods of use thereof 奥迪曼药业科技有限公司 2024-01-05 CN claimed
US-11779681-B2 Macroscopically alignable, injectable, soft hydrogel composition DWI—LEIBNIZ-INSTITUT FÜR INTERAKTIVE MATERIALIEN E.V. (DE) 2023-10-10 US claimed
EP-4218795-A2 PTH COMPOUNDS WITH LOW PEAK-TO-TROUGH RATIOS Ascendis Pharma Bone Diseases A/S (DK) 2023-08-02 EP claimed
EP-4192508-A1 CONJUGATES COMPRISING REVERSIBLE LINKERS AND USES THEREOF Ascendis Pharma A/S (DK) 2023-06-14 EP claimed
US-20230110994-A1 CONJUGATES UNDERGOING INTRAMOLECULAR REARRANGEMENTS ASCENDIS PHARMA A/S (DK) 2023-04-13 US claimed
US-20230065814-A1 CONJUGATES OF-ELECTRON-PAIR-DONATING HETEROAROMATIC NITROGEN-COMPRISING COMPOUNDS ASCENDIS PHARMA A/S (DK) 2023-03-02 US claimed
EP-4084872-A1 CONJUGATES UNDERGOING INTRAMOLECULAR REARRANGEMENTS Ascendis Pharma A/S (DK) 2022-11-09 EP claimed
EP-3693031-B1 MACROSCOPICALLY ALIGNABLE, INJECTABLE, SOFT HYDROGEL COMPOSITION DWI LEIBNIZ INSTITUT FUER INTERAKTIVE MAT E V (DE) 2022-11-02 EP claimed
CN-115175738-A Conjugates undergoing intramolecular rearrangement 阿森迪斯药物股份有限公司 2022-10-11 CN claimed
EP-0907668-A1 AMPHIPHILIC, SEGMENTED COPOLYMER OF CONTROLLED MORPHOLOGY AND OPHTHALMIC DEVICES INCLUDING CONTACT LENSES MADE THEREFROM Novartis AG (CH) 1999-04-14 EP claimed
US-5807944-A Amphiphilic, segmented copolymer of controlled morphology and ophthalmic devices including contact lenses made therefrom CIBA VISION CORPORATION (US) 1998-09-15 US claimed
WO-1997049740-A9 AMPHIPHILIC, SEGMENTED COPOLYMER OF CONTROLLED MORPHOLOGY AND OPHTHALMIC DEVICES INCLUDING CONTACT LENSES MADE THEREFROM 1998-04-30 WO claimed
EP-0688207-B1 LIPID-POLYMER CONJUGATES AND LIPOSOMES SEQUUS PHARM INC (US) 1998-01-28 EP claimed
WO-1997049740-A1 AMPHIPHILIC, SEGMENTED COPOLYMER OF CONTROLLED MORPHOLOGY AND OPHTHALMIC DEVICES INCLUDING CONTACT LENSES MADE THEREFROM NOVARTIS AG (CH) 1997-12-31 WO claimed
US-5631018-A Lipid-polymer conjugates and liposomes SEQUUS PHARMACEUTICALS, INC. (US) 1997-05-20 US claimed
EP-0688207-A1 LIPID-POLYMER CONJUGATES AND LIPOSOMES SEQUUS PHARMACEUTICALS, INC. (US) 1995-12-27 EP claimed
WO-1994020073-A1 LIPID-POLYMER CONJUGATES AND LIPOSOMES LIPOSOME TECHNOLOGY, INC. (US) 1994-09-15 WO claimed
US-4916195-A SULFO-ESTERIFICATION, RING-OPENING POLYMERIZATION SHINETSU CHEMICAL INDUSTRIES, LTD. (JP) 1990-04-10 US claimed
EP-0290109-A2 Poly (N-acylethyleneimine)grafted polysiloxane and its preparation Nippon Paint Co., Ltd. (JP) 1988-11-09 EP claimed